Home Akorn Reaffirms 2015 Revenue and EPS Guidance
 

Keywords :   


Akorn Reaffirms 2015 Revenue and EPS Guidance

2015-03-10 16:40:35| Biotech - Topix.net

Akorn, Inc. reaffirms its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million and adjusted diluted earnings per share of between $1.88 and $1.98. Akorn's Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 10:15 a.m. EDT at the Loews Miami Beach Hotel in Miami Beach, Florida.

Tags: revenue guidance eps reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 11A
01.07Summary for Hurricane Beryl (AT2/AL022024)
More »